− Treatment




Large Increases in HIV Suppression Needed to Reduce New Infections in Critical Population

NIAID image for Oct 20 blog - HIV on a T cell - resized

NIH-Funded Study Aims to Identify and Treat HIV-Infected Men Who Have Sex With Men Achieving moderate reduction of new HIV infections among men who have sex with men (MSM) will depend on significantly increasing the percentage of HIV-infected MSM whose viral load is suppressed to undetectable levels, according to a new mathematical model based on…

Final USCA 2016 Facebook Live Events Focus on Viral Suppression and Conference Highlights

PLWHA discuss viral suppression at USCA

On the closing day of the 2016 U.S. Conference on AIDS (USCA), September 18, in Hollywood, Florida, shared more conference highlights via two Facebook Live events. People Living with HIV Discussed What New Science on Viral Suppression Means to Them Dr. Rich Wolitski held a conversation with four other people living with HIV about…

NIH’s Dr. Carl Dieffenbach Discusses HIV Treatment Science at 2016 Ryan White Conference

Facebook Live with Carl Dieffenbach

As the 2016 National Ryan White Conference on HIV Care and Treatment wound down in Washington, DC, NIH’s Dr. Carl Dieffenbach and his colleague Anne Rancourt joined us for a conversation on Facebook Live about HIV treatment. They discussed what scientists now know about the benefits of HIV treatment and when people diagnosed with HIV…

Updated: Common Patient Assistance Program Application Reduces Barriers to HIV Medication Access

Image on the Common Assistance Application

This month, the U.S. Department of Health and Human Services (HHS), in collaboration with seven pharmaceutical companies and the National Alliance of State and Territorial AIDS Directors  (NASTAD), released an updated Common Patient Assistance Program Application  (CPAPA).  Developed in 2012, the CPAPA is intended to be used by both people living with HIV and their…

Viral Suppression: The Struggle is Real

Rich Wolitski - Headshot - no jacket not smiling - cropped June 2016

Recently, I’ve been thinking and talking a lot about the importance of viral suppression. For people living with HIV, getting the virus under control is the most important thing we can do. It’s the key to our own survival, reducing deaths, and preventing new infections. Viral suppression reflects not only the quality of medical care,…

CMS, CDC, & HRSA Launch HIV Health Improvement Affinity Group for State Medicaid Programs

CMS logo cropped June 2016

This week the Centers for Medicaid and Medicare Services (CMS), the Centers for Disease Control and Prevention (CDC), and the Health Resources and Services Administration (HRSA) announced the launch of a new joint initiative: the HIV Health Improvement Affinity Group [PDF 91 KB]. The HIV Health Improvement Affinity Group will bring together state public health…

CROI 2016 Plenary Session on HIV in Transgender Populations (Video)

Dr. Tonya Poteat - image for CROI2016 blog

The 2016 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston last month featured a first-ever plenary session on HIV in transgender populations by Dr. Tonia C. Poteat. I had the chance to visit with her following her presentation. I encourage you to watch Dr. Poteat’s plenary address at CROI. Dr. Poteat, an Assistant Professor…

NIAID to Fund Further Study of Dapivirine Vaginal Ring for HIV Prevention Investment in HOPE Trial Augments Development of Next-Generation Prevention Tools

NIAID image - vaginal ring - ASPIRE study

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), announced today that it would move forward with an open-label extension study of an HIV prevention tool for women: a silicone ring that continuously releases the experimental antiretroviral drug dapivirine in the vagina. The new study builds on…